CYTK — CYTOKINETICS INC

Ownership history in Squarepoint Ops LLC  ·  34 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in CYTOKINETICS INC (CYTK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2017 Q4)
Avg. % of fund
0.01%
First filed
2016 Q1
Last filed
2025 Q3
Quarters held
34
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 105,180 +86,782 +471.7% 0.01% $5.8M $54.96
2025 Q2 REDUCED 18,398 -85,480 -82.3% 0.00% $608K $33.04
2025 Q1 ADDED 103,878 +93,378 +889.3% 0.01% $4.2M $40.19
2024 Q4 REDUCED 10,500 -9,339 -47.1% 0.00% $494K $47.04
30 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CYTK price (monthly, adj. close)

Other funds also holding CYTK

As of 2025 Q4 — sorted by position size

Foresite Capital Management IV, LLC 3Y 7Y 12.68% Sarissa Capital Management LP 3Y 7Y 11.3% DAFNA Capital Management LLC 3Y 7Y 5.48% Integral Health Asset Management, LLC 3Y 4.42% Rosalind Advisors, Inc. 4.36% Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.22% Melqart Asset Management (UK) Ltd 3Y 7Y 3.9% Exome Asset Management LLC 3.79% Deep Track Capital, LP 3Y 3.78% Checkpoint Capital L.P. 3.31%
← Back to Squarepoint Ops LLC Holdings